PLRX · Company research

Pliant Therapeutics, Inc. (PLRX): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20260.99$66,120,490.0843930490.08————0.40032748919269098967—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.